The University of Chicago Header Logo

Connection

Jon E. Grant to Naltrexone

Back to Details
This is a "connection" page, showing publications Jon E. Grant has written about Naltrexone.
Jon E. Grant
Connection Strength
5.530
Naltrexone
  1. Use of Anticraving Agents in the Treatment of Exhibitionism and Frotteuristic Disorder. J Clin Psychopharmacol. 2021 Sep-Oct 01; 41(5):611-612.
    View in: PubMed
    Score: 0.704
  2. Naltrexone and Disulfiram Treatment Response in Veterans With Alcohol Dependence and Co-Occurring Problem-Gambling Features. J Clin Psychiatry. 2017 Nov/Dec; 78(9):e1299-e1306.
    View in: PubMed
    Score: 0.540
  3. The opiate antagonist, naltrexone, in the treatment of trichotillomania: results of a double-blind, placebo-controlled study. J Clin Psychopharmacol. 2014 Feb; 34(1):134-8.
    View in: PubMed
    Score: 0.416
  4. Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study. Br J Psychiatry. 2010 Oct; 197(4):330-1.
    View in: PubMed
    Score: 0.330
  5. A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependence. Eur Neuropsychopharmacol. 2010 Nov; 20(11):823-8.
    View in: PubMed
    Score: 0.326
  6. A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania. Biol Psychiatry. 2009 Apr 01; 65(7):600-6.
    View in: PubMed
    Score: 0.295
  7. Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. Psychopharmacology (Berl). 2008 Nov; 200(4):521-7.
    View in: PubMed
    Score: 0.282
  8. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. J Clin Psychiatry. 2008 May; 69(5):783-9.
    View in: PubMed
    Score: 0.279
  9. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry. 2006 Feb; 163(2):303-12.
    View in: PubMed
    Score: 0.239
  10. Understanding and treating kleptomania: new models and new treatments. Isr J Psychiatry Relat Sci. 2006; 43(2):81-7.
    View in: PubMed
    Score: 0.238
  11. Outcome study of kleptomania patients treated with naltrexone: a chart review. Clin Neuropharmacol. 2005 Jan-Feb; 28(1):11-4.
    View in: PubMed
    Score: 0.222
  12. Sex differences in pain and hypothalamic-pituitary-adrenocortical responses to opioid blockade. Psychosom Med. 2004 Mar-Apr; 66(2):198-206.
    View in: PubMed
    Score: 0.209
  13. An open-label study of naltrexone in the treatment of kleptomania. J Clin Psychiatry. 2002 Apr; 63(4):349-56.
    View in: PubMed
    Score: 0.183
  14. Adolescent kleptomania treated with naltrexone--a case report. Eur Child Adolesc Psychiatry. 2002 Apr; 11(2):92-5.
    View in: PubMed
    Score: 0.183
  15. A case of kleptomania and compulsive sexual behavior treated with naltrexone. Ann Clin Psychiatry. 2001 Dec; 13(4):229-31.
    View in: PubMed
    Score: 0.179
  16. An open naltrexone treatment study in pathological gambling disorder. Int Clin Psychopharmacol. 2001 Sep; 16(5):285-9.
    View in: PubMed
    Score: 0.176
  17. Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking. Alcohol Clin Exp Res. 2014 Oct; 38(10):2622-9.
    View in: PubMed
    Score: 0.109
  18. Compulsive buying treated with motivational interviewing and imaginal desensitization. Ann Clin Psychiatry. 2011 Aug; 23(3):226-7.
    View in: PubMed
    Score: 0.087
  19. Augmentation with naltrexone to treat compulsive sexual behavior: a case series. Ann Clin Psychiatry. 2010 Feb; 22(1):56-62.
    View in: PubMed
    Score: 0.079
  20. Naltrexone effect on physiological and subjective response to a cold pressor task. Biol Psychol. 2008 Feb; 77(2):233-6.
    View in: PubMed
    Score: 0.067
  21. Addicted to hair pulling? How an alternate model of trichotillomania may improve treatment outcome. Harv Rev Psychiatry. 2007 Mar-Apr; 15(2):80-5.
    View in: PubMed
    Score: 0.064
  22. Safety of high-dose naltrexone treatment: hepatic transaminase profiles among outpatients. Clin Neuropharmacol. 2006 Mar-Apr; 29(2):77-9.
    View in: PubMed
    Score: 0.060
  23. Pharmacotherapy outcome in older pathological gamblers: a preliminary investigation. J Geriatr Psychiatry Neurol. 2004 Mar; 17(1):9-12.
    View in: PubMed
    Score: 0.052
  24. Treatment of compulsive sexual behaviour with naltrexone and serotonin reuptake inhibitors: two case studies. Int Clin Psychopharmacol. 2002 Jul; 17(4):201-5.
    View in: PubMed
    Score: 0.047
  25. A preliminary report on possible naltrexone and nonsteroidal analgesic interactions. J Clin Psychopharmacol. 2001 Dec; 21(6):632-4.
    View in: PubMed
    Score: 0.045
  26. Demographic and clinical features of 131 adult pathological gamblers. J Clin Psychiatry. 2001 Dec; 62(12):957-62.
    View in: PubMed
    Score: 0.045
  27. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry. 2001 Jun 01; 49(11):914-21.
    View in: PubMed
    Score: 0.043
  28. The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study. Psychiatry Res. 2009 Mar 31; 166(1):76-84.
    View in: PubMed
    Score: 0.018
  29. Pathological gambling. Current status and new treatments. Minn Med. 2002 Jul; 85(7):48-50, 52.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.